BioVie: Cautiously Optimistic Ahead Of Phase 3 Alzheimer's Data Unblinding
Seeking Alpha,
Summary Blinded Phase 3 data of NE3107 in Alzheimer's appear to indicate robust cognitive and biomarker efficacy.
Summary Blinded Phase 3 data of NE3107 in Alzheimer's appear to indicate robust cognitive and biomarker efficacy.
. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase…